Celgene Corp. (CELG)
| Sector: | Health Care |
| |
| Super Investor Stats: | |
| Ownership count: | 0 |
| Ownership rank: | -- |
| % of all portfolios: | 0% |
| |
| History |
Portfolio Manager |
Activity ▼ |
Share change |
% change to portfolio |
| Q1 2019 |
| ≡ |
David Abrams - Abrams Capital Management |
Buy |
6,752,869 |
17.89 |
| ≡ |
Seth Klarman - Baupost Group |
Buy |
4,000,000 |
3.27 |
| ≡ |
Daniel Loeb - Third Point |
Buy |
1,750,000 |
1.85 |
| ≡ |
Prem Watsa - Fairfax Financial Holdings |
Buy |
14,500 |
0.07 |
| Q4 2018 |
| ≡ |
Bill Miller - Miller Value Partners |
Add 0.51% |
4,250 |
0.01 |
| Q3 2018 |
| ≡ |
Bill Miller - Miller Value Partners |
Add 19.04% |
133,040 |
0.40 |
| Q2 2018 |
| ≡ |
Bill Miller - Miller Value Partners |
Add 68.80% |
284,850 |
0.87 |
| Q1 2018 |
| ≡ |
Bill Miller - Miller Value Partners |
Add 18720.68% |
411,855 |
1.61 |
| Q4 2017 |
| ≡ |
David Rolfe - Wedgewood Partners |
Add 42.19% |
285,542 |
1.20 |
| ≡ |
Thomas Russo - Gardner Russo & Quinn |
Buy |
500 |
0.00 |
| Q2 2017 |
| ≡ |
David Rolfe - Wedgewood Partners |
Add 316.36% |
607,402 |
2.42 |
| ≡ |
Lee Ainslie - Maverick Capital |
Buy |
19,150 |
0.03 |
| ≡ |
Bill Miller - Miller Value Partners |
Buy |
2,200 |
0.01 |
| Q1 2017 |
| ≡ |
David Rolfe - Wedgewood Partners |
Buy |
192,000 |
0.62 |
| Q1 2016 |
| ≡ |
Lee Ainslie - Maverick Capital |
Add 105.88% |
2,520 |
0.01 |
| Q4 2015 |
| ≡ |
Lee Ainslie - Maverick Capital |
Add 13.88% |
290 |
0.00 |
| Q1 2015 |
| ≡ |
Lee Ainslie - Maverick Capital |
Buy |
2,230 |
0.00 |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.